Why
Immunosuppression Is Not Necessary For Implantation of BCRO Fetal
Precursor Cell
Transplants

Immunosuppression to use it or not to use it
with fetal precursor cell transplantation has been a subject of heated
arguments among physicians practicing this field of medicine for the past
20+ years.

European physicians have not used
immunosuppression after cell transplantation, even of cells of animal fetal
origin, because they observed in their clinical practice that

allergic reactions were infrequent (incidence
less than 5%),

anaphylactic shock was rare, and

allergic reactions never caused death of a
patient(!),

but they used a premedication by
antihistamins and cortison.

This was established beyond any legal doubt by the
investigation ordered by German Supreme Court in the case # 1 BvR 420/97.

Since in Europe ~ 5 million patients have been
treated by various forms of cell transplantation, mostly of animal
fetal origin, and none of them received immunosuppression after implantation, there was hardly any need to search for scientific
proofs. Res ipsa loquitur! (Facts speak for themselves!)

There are many published medical reports on
hundreds of patients showing that changes of laboratory parameters of
the immune system function before and after fetal precursor cell transplantation are
minimal & statistically not significant.

This confirms the absence of any noticeable
clinical immune reactions after cell transplantation providing
cell transplants were prepared properly, such as by BCRO method.

U.S. physicians are adamant that long term
immunosuppression must be used after fetal precursor cell transplantation although the
total U.S. experience amounts to less than a few thousand patients (and most
of these patients had neurotransplantation where immunosuppression is
absolutely unnecessary, as it is commonly known that implanted fetal
brain tissue is non-antigenic).

The problem lies with immunologists.

The European fathers of immunology could be
convinced already in 60-ies to personally observe the patient treatments
with live fetal cell xeno-transplants and recognize - to their great surprise -
that the recipient patients not only did not die of anaphylactic shock, on
the contrary they exhibited no clinically apparent immune reactions
whatsoever.

U.S. immunologists have never permitted any fetal
cell transplantation to be done without immunosuppression via various
political channels, hospital committees, medical associations, medical
malpractice insurance companies, and

thus - outside of clinical trials carried
out in the U.S. with BCRO cell transplants in 1993 and 1995 - no U.S.
physician has had an opportunity to 'learn the truth'.

Until we will learn what life is, and many
philosophers believe that it will never happen, and thus cannot explain
many aspects of the function of living bodies, we have to be satisfied
with the fact that implantation of 'state-of-art' BCRO type fetal precursor cell transplants
does not cause untoward immune or allergic reactions.

The use of high dose immunosuppression has been
one of the main reasons why the success rate of cell transplantation has
been so poor in the U.S, as compared with Europe.

Long term immunosuppression is not only dangerous
to the patients, it is also detrimental to the fetal precursor cell transplants,
because these are very young cells, enormously sensitive to any toxin, and
immunosuppressants are indeed highly toxic!

The controversy should have ended when we
presented the existence of such method to the U.S. FDA in 1997.

The negative attitude of pharmaceutical
industry toward cell transplantation make no sense: throughout its 80+
years long history fetal precursor cell transplantation has been used predominantly

for patients with no longer treatable serious diseases who have not
responded, or no longer responded, to the usual, or standard, medical
treatment, or

for those who suffered from incurable diseases without
any known treatment,

in other words cell transplantation has
not replaced the orthodox medical therapies, which bring profits to the
pharmaceutical industry.

So there has been no need to look at cell
transplantation as a competition.

BCRO fetal precursor cell
transplantation, has been used successfully for 80+
years as treatment of many diseases

for which modern medicine has had no therapy
(i.e. incurable), or

in which 'state-of-art' therapies stopped being
effective (i.e. no longer treatable),

in documented over 5 millions of patients worldwide.
Physicians can learn about it in a textbook by E. Michael Molnar, M.D.:
Fetal Precursor Cell
Transplantation, BCRO Fetal Precursor Cell Transplantation", published
in 2014 by www.amazon.com
On
the same web site the general readership can find out all about it in
the book by the same author: Treatment of Incurable and No Longer
Treatable Diseases, published in January 2015, as well as in his
autobiography: Diseases and Genocide are
not Our Destiny. You can buy it as 'free reader download for PC' as
well as Kindle Book.